Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 12 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 298 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 47,432 followers.

Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease - Saglimbene, VM - 2017 | Cochrane Library https://t.co/9uzxDuvYbs

04 Oct 2021

Reply Repost Favourite

RT @CochraneKidney: Continuous erythropoiesis receptor activator for the anaemia of CKD https://t.co/fIrKU54mVi https://t.co/o3g3b05FWM

11 Aug 2017

Reply Repost Favourite

Another example of why CKD is a hopeless term and should be changed? https://t.co/exvf8tThBN

11 Aug 2017

Reply Repost Favourite

#Cochrane_Publica #Rev_Sist Metoxi-PEG-epoetina beta #CERA en #anemia en #Enfermedad_renal_crónica https://t.co/BGjXV6FAZ2 @SENefrologia

10 Aug 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.